DelveInsight Business Research, LLP: BREYANZI Demonstrates Continued Growth in the Competitive CAR-T Market | DelveInsight
BREYANZI has significant market potential due to its innovative approach as a CD19-directed chimeric antigen receptor (CAR) T-cell therapy. The growing prevalence of hematologic malignancies ...
BREYANZI Demonstrates Continued Growth in the Competitive CAR-T Market | DelveInsight
DelveInsight's 'BREYANZI Market Size, Forecast, and Market Insight Report' highlights the details around BREYANZI, a CD19-directed CAR ...
News-Medical.Net1d
Study investigates genetic mutations linked to occupational exposures
Occupational and environmental exposures can put specific groups of people at higher risk of cancer, including firefighters. A new study by investigators at Mass General Brigham examines a cancer ...
News-Medical.Net1d
Study links firefighting chemicals to increased glioma risk
A new study uncovered an association between exposure to chemicals commonly used in firefighting and glioma risk, reinforcing earlier research that has suggested a link between firefighting and the ...
Good Faith Efforts Required Before Filing Civil Discovery Motions: New York Courts Say: ‘We Mean It!’
Recent court decisions applying 22 NYCRR §202.20-f appear to have made it clear to civil attorneys that merely sending out a ...
InflaRx Showcases Vilobelimab’s Role in Immuno-Dermatology at the 2025 AAD Annual Meeting
InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, today announced the presentation of multiple posters describing the ...
New report confirms Smith+Nephew’s OXINIUM™ Technology is the best performing bearing surface at 20 years for total hip arthroplasty
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, is pleased to announce that the latest annual report ...